Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report ; volume:6 ; number:1 ; day:17 ; month:7 ; year:2006 ; pages:1-6 ; date:12.2006
BMC cancer ; 6, Heft 1 (17.7.2006), 1-6, 12.2006
- Creator
-
Sprinzl, Martin F.
- Contributor
-
Schimanski, Carl C.
Möhler, Markus
Schadmand-Fischer, Simin
Galle, Peter R.
Kanzler, Stephan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-6-190
- URN
-
urn:nbn:de:1111-2016030341191
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sprinzl, Martin F.
- Schimanski, Carl C.
- Möhler, Markus
- Schadmand-Fischer, Simin
- Galle, Peter R.
- Kanzler, Stephan
- SpringerLink (Online service)
Other Objects (12)
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Schwere Akne unter Therapie eines metastasierten kolorektalen Karzinoms mit monoklonalem Anti-EGF-Rezeptor-Antikörper Cetuximab (Erbitux®)
Photochemical internalization of gemcitabine is safe and effective in locally advanced inoperable cholangiocarcinoma
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
EGF
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Schwere Akne unter Therapie eines metastasierten kolorektalen Karzinoms mit monoklonalem Anti-EGF-Rezeptor-Antikörper Cetuximab (Erbitux®)
Photochemical internalization of gemcitabine is safe and effective in locally advanced inoperable cholangiocarcinoma
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
EGF
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Fehlende Radiosensitivierung HPV-positiver HNSCC-Zelllinien bei Inhibition des EGF Rezeptors durch Cetuximab
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Radiolabeling of anti-EGFR antibody, Cetuximab, overcomes the radiotherapy resistance of Cetuximab resistant head and neck cancer cells
Schwere Akne unter Therapie eines metastasierten kolorektalen Karzinoms mit monoklonalem Anti-EGF-Rezeptor-Antikörper Cetuximab (Erbitux®)
Photochemical internalization of gemcitabine is safe and effective in locally advanced inoperable cholangiocarcinoma
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab
EGF
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients